Reuters logo
BRIEF-Adocia initiates phase 1b clinical study on dose-proportionality of Biochaperone combo
June 7, 2017 / 4:17 PM / 3 months ago

BRIEF-Adocia initiates phase 1b clinical study on dose-proportionality of Biochaperone combo

June 7 (Reuters) - ADOCIA SA:

* ADOCIA INITIATES A PHASE 1B CLINICAL STUDY ON THE DOSE-PROPORTIONALITY OF BIOCHAPERONE COMBO IN PEOPLE WITH TYPE 2 DIABETES

* STUDY RESULTS ARE EXPECTED IN Q4 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below